CBS and chronic myelogenous leukemia, BCR-ABL1 positive: Inhibiting tumor growth was achieved through CBS gene knockout and the application of aminooxyacetic acid (AOAA), a broad inhibitor of PLP-dependent enzymes, on CML-derived K562 cells, which led to the activation of the apoptosis pathway.